Kourzeq Oral Paste Launched For Canker Sore And Oral Inflammatory Lesions
- byDoctor News Daily Team
- 22 July, 2025
- 0 Comments
- 0 Mins
A new study released by the MidAmerica Pharmaceuticals unveiled a reasonable solution for the painful issue caused by canker sores with the launch of KOURZEQ™ (triamcinolone acetonide dental paste USP, 0.1%). This FDA-approved prescription oral paste is tailored to efficiently treat oral lesions, providing relief to individuals suffering from the discomfort of canker sores.
Canker sores, also known as the aphthous ulcers, are shallow lesions found around the soft tissues inside the mouth. KOURZEQ is formulated to accelerate the healing process by reducing inflammation, offering relief from burning sensations, and alleviating pain associated with canker sores.
A distinctive feature of KOURZEQ is its exclusive availability through telehealth services, made possible through a strategic partnership between MidAmerica Pharmaceuticals and BeyondMD®. Interested consumers can visit kourzeq.doctalkgo.com to set up a virtual consultation with a qualified healthcare professional. If deemed appropriate following the assessment, the prescription for KOURZEQ can be ordered and delivered directly to the patient's doorstep.
Eve del Rio, MD, Chief Medical Officer for MidAmerica Pharmaceuticals, expressed the company's commitment to providing a swift and effective remedy for canker sores. "We are pleased to be offering a new FDA-approved option for those living with, and suffering from, canker sores. We are confident that KOURZEQ will make a positive difference for those suffering from canker sores."
Linda Brennan, the MidAmerica Pharmaceuticals CEO added saying "After seeing firsthand how painful canker sores can be, I created MidAmerica Pharmaceuticals so that we can bring a solution to millions of people."
The telehealth distribution model aims to streamline the process of obtaining both expert healthcare advice and access to KOURZEQ. John Bernard, M.D., Medical Director for BeyondMD, emphasized the relief this will bring to canker sore sufferers.
Source:
Pharmaceuticals, M. (2023, November 14). MidAmerica Pharmaceuticals Launches KOURZEQTM Oral Paste - an FDA Approved Prescription Medication that Helps Canker Sores Heal Faster. MidAmerica Pharmaceuticals.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
DME Gujarat extends PG Ayurveda, Homeopathy round...
- 05 November, 2025
NEET counselling: CENTAC publishes round 3 provisi...
- 05 November, 2025
Marksans Pharma UK arm gets marketing nod for Exem...
- 05 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!